These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7792806)

  • 1. Molecular characterization of the mineralocorticoid receptor in pseudohypoaldosteronism.
    Zennaro MC; Borensztein P; Jeunemaitre X; Armanini D; Corvol P; Soubrier F
    Steroids; 1995 Jan; 60(1):164-7. PubMed ID: 7792806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No alteration in the primary structure of the mineralocorticoid receptor in a family with pseudohypoaldosteronism.
    Zennaro MC; Borensztein P; Jeunemaitre X; Armanini D; Soubrier F
    J Clin Endocrinol Metab; 1994 Jul; 79(1):32-8. PubMed ID: 8027248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudohypoaldosteronism: molecular characterization of the mineralocorticoid receptor.
    Komesaroff PA; Verity K; Fuller PJ
    J Clin Endocrinol Metab; 1994 Jul; 79(1):27-31. PubMed ID: 8027241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineralocorticoid resistance.
    Zennaro MC
    Steroids; 1996 Apr; 61(4):189-92. PubMed ID: 8732998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult nephron-specific MR-deficient mice develop a severe renal PHA-1 phenotype.
    Canonica J; Sergi C; Maillard M; Klusonova P; Odermatt A; Koesters R; Loffing-Cueni D; Loffing J; Rossier B; Frateschi S; Hummler E
    Pflugers Arch; 2016 May; 468(5):895-908. PubMed ID: 26762397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1.
    Tajima T; Kitagawa H; Yokoya S; Tachibana K; Adachi M; Nakae J; Suwa S; Katoh S; Fujieda K
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4690-4. PubMed ID: 11134129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mineralocorticoid resistance: pseudohypoaldosteronism type 1].
    Fernandes-Rosa FL; Antonini SR
    Arq Bras Endocrinol Metabol; 2007 Apr; 51(3):373-81. PubMed ID: 17546235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No apparent mineralocorticoid receptor defect in a series of sporadic cases of pseudohypoaldosteronism.
    Arai K; Tsigos C; Suzuki Y; Listwak S; Zachman K; Zangeneh F; Rapaport R; Chanoine JP; Chrousos GP
    J Clin Endocrinol Metab; 1995 Mar; 80(3):814-7. PubMed ID: 7883835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudohypoaldosteronism type 1 due to a novel mutation in the mineralocorticoid receptor gene.
    Loomba-Albrecht LA; Nagel M; Bremer AA
    Horm Res Paediatr; 2010; 73(6):482-6. PubMed ID: 20453518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor mutations.
    Zennaro MC; Fernandes-Rosa F
    J Endocrinol; 2017 Jul; 234(1):T93-T106. PubMed ID: 28348114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudohypoaldosteronism due to renal and multisystem resistance to mineralocorticoids respond differently to carbenoxolone.
    Hanukoglu A; Joy O; Steinitz M; Rosler A; Hanukoglu I
    J Steroid Biochem Mol Biol; 1997 Jan; 60(1-2):105-12. PubMed ID: 9182864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudohypoaldosteronism: options for consideration.
    Komesaroff PA
    Steroids; 1995 Jan; 60(1):168-72. PubMed ID: 7792807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mineralocorticoid receptor antagonizes Dot1a-Af9 complex to increase αENaC transcription.
    Zhang X; Zhou Q; Chen L; Berger S; Wu H; Xiao Z; Pearce D; Zhou X; Zhang W
    Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1436-44. PubMed ID: 24026182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel mutation in the human mineralocorticoid receptor gene in a german family with autosomal-dominant pseudohypoaldosteronism type 1: further evidence for marked interindividual clinical heterogeneity.
    Riepe FG; Krone N; Morlot M; Ludwig M; Sippell WG; Partsch CJ
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1683-6. PubMed ID: 12679457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mineralocorticoid receptor mutations and a severe recessive pseudohypoaldosteronism type 1.
    Hubert EL; Teissier R; Fernandes-Rosa FL; Fay M; Rafestin-Oblin ME; Jeunemaitre X; Metz C; Escoubet B; Zennaro MC
    J Am Soc Nephrol; 2011 Nov; 22(11):1997-2003. PubMed ID: 21903996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism.
    Pujo L; Fagart J; Gary F; Papadimitriou DT; Claës A; Jeunemaître X; Zennaro MC
    Hum Mutat; 2007 Jan; 28(1):33-40. PubMed ID: 16972228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological and molecular aspects of mineralocorticoid receptor action in pseudohypoaldosteronism: a responsiveness test and therapy.
    Arai K; Tsigos C; Suzuki Y; Irony I; Karl M; Listwak S; Chrousos GP
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1019-23. PubMed ID: 7962269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivating mutations of the mineralocorticoid receptor in Type I pseudohypoaldosteronism.
    Sartorato P; Khaldi Y; Lapeyraque AL; Armanini D; Kuhnle U; Salomon R; Caprio M; Viengchareun S; Lombès M; Zennaro MC
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):119-25. PubMed ID: 15134810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional polymorphisms in the mineralocorticoid receptor and amirolide-sensitive sodium channel genes in a patient with sporadic pseudohypoaldosteronism.
    Arai K; Nakagomi Y; Iketani M; Shimura Y; Amemiya S; Ohyama K; Shibasaki T
    Hum Genet; 2003 Jan; 112(1):91-7. PubMed ID: 12483305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel frameshift mutation in NR3C2 leads to decreased expression of mineralocorticoid receptor: a family with renal pseudohypoaldosteronism type 1.
    Kawashima Sonoyama Y; Tajima T; Fujimoto M; Hasegawa A; Miyahara N; Nishimura R; Hashida Y; Hayashi A; Hanaki K; Kanzaki S
    Endocr J; 2017 Jan; 64(1):83-90. PubMed ID: 27725360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.